York, United Kingdom
York, United Kingdom

Time filter

Source Type

Buyel J.F.,RWTH Aachen | Buyel J.F.,Fraunhofer Institute for Molecular Biology and Applied Ecology | Twyman R.M.,TRM Ltd | Fischer R.,RWTH Aachen | And 2 more authors.
Biotechnology Advances | Year: 2017

Gene technology has facilitated the biologization of manufacturing, i.e. the use and production of complex biological molecules and systems at an industrial scale. Monoclonal antibodies (mAbs) are currently the major class of biopharmaceutical products, but they are typically used to treat specific diseases which individually have comparably low incidences. The therapeutic potential of mAbs could also be used for more prevalent diseases, but this would require a massive increase in production capacity that could not be met by traditional fermenter systems. Here we outline the potential of plants to be used for the very-large-scale (VLS) production of biopharmaceutical proteins such as mAbs. We discuss the potential market sizes and their corresponding production capacities. We then consider available process technologies and scale-down models and how these can be used to develop VLS processes. Finally, we discuss which adaptations will likely be required for VLS production, lessons learned from existing cell culture-based processes and the food industry, and practical requirements for the implementation of a VLS process. © 2017 The Authors.


News Article | May 9, 2017
Site: www.marketwired.com

Tenth annual IMPACT conference showcases new digital technologies revolutionizing human resources and the world of work HORSHAM, PA--(Marketwired - May 9, 2017) - Phenom People, the leader in Talent Relationship Marketing, today announced it will be exhibiting and unveiling new product features during IMPACT 2017. The Bersin by Deloitte event will take place May 22-25 at The Diplomat Resort & Spa in Hollywood, Fla. "We are excited to be a part of IMPACT 2017 and look forward to showing off our latest features to the HR and talent leaders attending the conference," said Mahe Bayireddi, CEO at Phenom People. "We are making huge advancements in the talent acquisition space, and we're thrilled to continue innovating and disrupting the way organizations attract, engage, nurture and convert top talent." The Phenom People Talent Relationship Marketing (TRM) Cloud Platform continues on a path of innovation and disruption in the talent acquisition space, transforming the way people search for jobs and how phenomenal companies find top talent. At IMPACT 2017, Phenom People will highlight the latest version of the Phenom People TRM Cloud Platform, which includes the following features: IMPACT is Bersin by Deloitte's annual research-based executive conference for HR, learning and talent executives and their teams. Themed "Unleashing the Power of Digital: A New World for HR," IMPACT 2017 will focus on the ways HR is responding to massive disruptions caused by the latest technologies, an explosion in analytics and artificial intelligence and changing definitions of work, workforces and worker expectations. It will also look at how these changes are driving a fundamental shift in the way leaders manage, guide and operate their organizations. About Phenom People Phenom People, the leader in Talent Relationship Marketing, helps companies attract phenomenal talent through personalized digital experience. The Phenom People Talent Relationship Marketing platform automates the complex process of driving awareness, interest, engagement, and acquisition for qualified talent. Phenom People helps some of the largest brands in the world attract phenomenal talent including AMN Healthcare, Citrix, Deloitte, General Motors, Hershey, Informatica and IPG Media. To learn more about Talent Relationship Marketing, please visit www.phenompeople.com.


News Article | May 17, 2017
Site: www.sciencedaily.com

When people develop a respiratory infection, recovery from their illness leaves behind an immunological memory that influences how they will respond to later infections. In a new study, researchers demonstrate for the first time that recovery from bacterial pneumonia changes the tissue that was infected, seeding the lungs with immune cells called resident memory T (TRM) cells. Differences in the numbers and activities of these lung TRM cells may be responsible for the increased susceptibility of young children and older adults to pneumonia and manipulating these cells may provide novel treatment options for curing pneumonia. The study appears in the journal Mucosal Immunology. Worldwide, pneumonia remains a serious public health burden. Each year more than one million children under the age of five die from pneumonia and associated complications. In the U.S., pneumonia is the most common reason for the hospitalization of children and accounts for nearly half of the infectious disease-related hospitalizations and deaths of older adults. To model the typical experience of most children, an experimental model received a series of mild and non-life threatening respiratory infections. A control model received sterile saline instead of infections. When compared to the control model, those with prior respiratory infections were profoundly resistant to severe (life-threatening) pneumonia. "Our study suggests that respiratory bacterial infections during childhood establish a novel type of antibacterial immunity," explained corresponding author Joseph Mizgerd, ScD, professor of medicine, microbiology and biochemistry at Boston University School of Medicine. "The TRM cells left behind after prior infections are more broadly effective than vaccine-generated immunity, providing protection against a wider spectrum of microbes that can infect the lungs." Young children and older adults are highly susceptible to pneumonia, but the factors that are responsible for preventing pneumonia in young healthy adults are still not understood. "We have only modest abilities to prevent or cure many of the infections that cause pneumonia. Defining the protective mechanisms normally preventing lung infections in most young healthy adults will lead to tests identifying who is susceptible and new approaches for preventing and treating the infections," added Mizgerd.


News Article | May 17, 2017
Site: www.eurekalert.org

(Boston) -- When people develop a respiratory infection, recovery from their illness leaves behind an immunological memory that influences how they will respond to later infections. In a new study, researchers demonstrate for the first time that recovery from bacterial pneumonia changes the tissue that was infected, seeding the lungs with immune cells called resident memory T (TRM) cells. Differences in the numbers and activities of these lung TRM cells may be responsible for the increased susceptibility of young children and older adults to pneumonia and manipulating these cells may provide novel treatment options for curing pneumonia. The study appears in the journal Mucosal Immunology. Worldwide, pneumonia remains a serious public health burden. Each year more than one million children under the age of five die from pneumonia and associated complications. In the U.S., pneumonia is the most common reason for the hospitalization of children and accounts for nearly half of the infectious disease-related hospitalizations and deaths of older adults. To model the typical experience of most children, an experimental model received a series of mild and non-life threatening respiratory infections. A control model received sterile saline instead of infections. When compared to the control model, those with prior respiratory infections were profoundly resistant to severe (life-threatening) pneumonia. "Our study suggests that respiratory bacterial infections during childhood establish a novel type of antibacterial immunity," explained corresponding author Joseph Mizgerd, ScD, professor of medicine, microbiology and biochemistry at Boston University School of Medicine. "The TRM cells left behind after prior infections are more broadly effective than vaccine-generated immunity, providing protection against a wider spectrum of microbes that can infect the lungs." Young children and older adults are highly susceptible to pneumonia, but the factors that are responsible for preventing pneumonia in young healthy adults are still not understood. "We have only modest abilities to prevent or cure many of the infections that cause pneumonia. Defining the protective mechanisms normally preventing lung infections in most young healthy adults will lead to tests identifying who is susceptible and new approaches for preventing and treating the infections," added Mizgerd. Funding for this study was provided by research grants from the National Institutes of Health (NIH) to J.P.M. (R01 AI115053, R01 HL068153, R01 HL079392, R35 HL135756), L.J.Q. (R01 HL111449) and M.R.J. (R01 HL104053), as well as by the NIH training grants (T32 HL007035, T32 AI007309).


News Article | May 16, 2017
Site: www.prweb.com

Building Engines, the commercial real estate industry’s innovation leader for on-demand property management operations software, today announced the release of its enhanced tenant services mobile app, “The Hive.” Building on the success of Building Engines’ previous tenant mobile app, The Hive enhances the tenant experience through improved convenience and customer service delivery. With this new mobile enhancement, commercial real estate (CRE) managers will improve tenant engagement while increasing satisfaction and retention. Powered by The Hive’s tenant-centered mobile capabilities, tenants can register visitors, submit service requests, review and approve estimates, as well as receive urgent updates and promotional broadcast messages from building management - anywhere, at any time. “Commercial property managers know that an improved tenant experience and deeper tenant engagement lead to increased satisfaction and higher tenant retention; however, only 20 percent of them believe they have the necessary tools to increase retention,” said Jody Saarmaa, Vice President, Product Management of Building Engines. “Our goal with The Hive is to give managers those tools. By empowering their tenants with greater visibility and control over their working environment through anywhere, anytime access to Building Engines’ tenant-facing capabilities, we’re confident that building managers will enhance tenant engagement, increase satisfaction and, ultimately, improve tenant retention.” The Building Engines 2016 Tenant Relationship Management (TRM) Survey Benchmark Report revealed that 54% of CRE professionals believe that modern property communication tools, such as mobile apps and online work order systems, increase tenant satisfaction. The report also confirmed that giving tenants mobile tools to identify problems and access resources tops CRE professionals’ wish lists. The Hive by Building Engines Provides New Tools for Stronger Tenant Relationships The Hive provides tenants and their building managers with a modern, mobile means to instantly communicate with management, address building issues and access resources whenever they may need them and wherever they may be. It includes new features that enable CRE professionals to improve tenant satisfaction and build stronger tenant relationships, including: The Hive takes the hassle out of managing a consumer-grade tenant mobile app. The powerful, free app is integrated with the rest of the Building Engines suite of functions, and is updated automatically to ensure quality. To help drive adoption, Building Engines provides easy-to-use promotional tools. The Hive is available immediately for Apple and Android devices at no charge to tenants whose property managers use Building Engines property management software. Tenant users can download the free app from the Apple App Store and the Google Play store. Building Engines is a cloud-based provider of property management software for progressive operations teams at commercial office, medical, retail and industrial real estate properties. Our web and mobile applications seamlessly connect property management teams with the activities, data and insights they need to improve operational efficiency, mitigate risk, improve tenant satisfaction and engagement and make more informed operational decisions. Clients of Building Engines include many of the leading public REITs, private owner/managers and third-party management firms in the United States and Canada. For more information about Building Engines, please visit: http://www.buildingengines.com. Android and Google Play are trademarks of Google Inc. Apple and App Store are trademarks of Apple Inc.


Vamvaka E.,University of Lleida | Twyman R.M.,TRM Ltd | Christou P.,University of Lleida | Christou P.,Catalan Institution for Research and Advanced Studies | Capell T.,University of Lleida
Biotechnology Advances | Year: 2014

The population of sub-Saharan Africa is at risk from multiple, poverty-related endemic diseases. HIV and malaria are the most prevalent, but they disproportionately affect different groups of people, i.e. HIV predominantly affects sexually-active adults whereas malaria has a greater impact on children and pregnant women. Nevertheless, there is a significant geographical and epidemiological overlap which results in bidirectional and synergistic interactions with important consequences for public health. The immunosuppressive effects of HIV increase the risk of infection when individuals are exposed to malaria parasites and also the severity of malaria symptoms. Similarly, acute malaria can induce a temporary increase in the HIV viral load. HIV is associated with a wide range of opportunistic infections that can be misdiagnosed as malaria, resulting in the wasteful misuse of antimalarial drugs and a failure to address the genuine cause of the disease. There is also a cumulative risk of toxicity when antiretroviral and antimalarial drugs are given to the same patients. Synergistic approaches involving the control of malaria as a strategy to fight HIV/AIDS and vice versa are therefore needed in co-endemic areas. Plant biotechnology has emerged as a promising approach to tackle poverty-related diseases because plant-derived drugs and vaccines can be produced inexpensively in developing countries and may be distributed using agricultural infrastructure without the need for a cold chain. Here we explore some of the potential contributions of plant biotechnology and its integration into broader multidisciplinary public health programs to combat the two diseases in developing countries. © 2014 Elsevier Inc.


Farre G.,John Innes Center | Twyman R.M.,TRM Ltd | Christou P.,University of Lleida | Christou P.,Catalan Institution for Research and Advanced Studies | And 2 more authors.
Current Opinion in Biotechnology | Year: 2015

Plant metabolic pathways are complex and often feature multiple levels of regulation. Until recently, metabolic engineering in plants relied on the laborious testing of ad hoc modifications to achieve desirable changes in the metabolic profile. However, technological advances in data mining, modeling, multigene engineering and genome editing are now taking away much of the guesswork by allowing the impact of modifications to be predicted more accurately. In this review we discuss recent developments in knowledge-based metabolic engineering strategies, that is the gathering and mining of genomic, transcriptomic, proteomic and metabolomic data to generate models of metabolic pathways that help to define and refine optimal intervention strategies. © 2014 Elsevier Ltd.


Masip G.,University of Lleida | Sabalza M.,University of Lleida | Perez-Massot E.,University of Lleida | Banakar R.,University of Lleida | And 6 more authors.
Trends in Plant Science | Year: 2013

European Union (EU) agricultural policy has been developed in the pursuit of laudable goals such as a competitive economy and regulatory harmony across the union. However, what has emerged is a fragmented, contradictory, and unworkable legislative framework that threatens economic disaster. In this review, we present case studies highlighting differences in the regulations applied to foods grown in EU countries and identical imported products, which show that the EU is undermining its own competitiveness in the agricultural sector, damaging both the EU and its humanitarian activities in the developing world. We recommend the adoption of rational, science-based principles for the harmonization of agricultural policies to prevent economic decline and lower standards of living across the continent. © 2013 Elsevier Ltd.


Buyel J.F.,RWTH Aachen | Buyel J.F.,Fraunhofer Institute for Molecular Biology and Applied Ecology | Twyman R.M.,TRM Ltd | Fischer R.,RWTH Aachen | Fischer R.,Fraunhofer Institute for Molecular Biology and Applied Ecology
Biotechnology Advances | Year: 2015

Plants offer the tantalizing prospect of low-cost automated manufacturing processes for biopharmaceutical proteins, but several challenges must be addressed before such goals are realized and the most significant hurdles are found during downstream processing (DSP). In contrast to the standardized microbial and mammalian cell platforms embraced by the biopharmaceutical industry, there are many different plant-based expression systems vying for attention, and those with the greatest potential to provide inexpensive biopharmaceuticals are also the ones with the most significant drawbacks in terms of DSP. This is because the most scalable plant systems are based on the expression of intracellular proteins in whole plants. The plant tissue must therefore be disrupted to extract the product, challenging the initial DSP steps with an unusually high load of both particulate and soluble contaminants. DSP platform technologies can accelerate and simplify process development, including centrifugation, filtration, flocculation, and integrated methods that combine solid-liquid separation, purification and concentration, such as aqueous two-phase separation systems. Protein tags can also facilitate these DSP steps, but they are difficult to transfer to a commercial environment and more generic, flexible and scalable strategies to separate target and host cell proteins are preferable, such as membrane technologies and heat/pH precipitation. In this context, clarified plant extracts behave similarly to the feed stream from microbes or mammalian cells and the corresponding purification methods can be applied, as long as they are adapted for plant-specific soluble contaminants such as the superabundant protein RuBisCO. Plant-derived pharmaceutical proteins cannot yet compete directly with established platforms but they are beginning to penetrate niche markets that allow the beneficial properties of plants to be exploited, such as the ability to produce 'biobetters' with tailored glycans, the ability to scale up production rapidly for emergency responses and the ability to produce commodity recombinant proteins on an agricultural scale. © 2015 Elsevier Inc.


Mukherjee K.,Fraunhofer Institute for Molecular Biology and Applied Ecology | Twyman R.M.,TRM Ltd | Vilcinskas A.,Fraunhofer Institute for Molecular Biology and Applied Ecology | Vilcinskas A.,Justus Liebig University
Progress in Biophysics and Molecular Biology | Year: 2015

Epigenetic inheritance refers to changes in gene expression that are heritable across generations but are not caused by changes in the DNA sequence. Many environmental factors are now known to cause epigenetic changes, including the presence of pathogens, parasites, harmful chemicals and other stress factors. There is increasing evidence that transcriptional reprogramming caused by epigenetic modifications can be passed from parents to offspring. Indeed, diseases such as cancer can occur in the offspring due to epigenetically-inherited gene expression profiles induced by stress experienced by the parent. Empirical studies to investigate the role of epigenetics in trans-generational gene regulation and disease require appropriate model organisms. In this review, we argue that selected insects can be used as models for human diseases with an epigenetic component because the underlying molecular mechanisms (DNA methylation, histone acetylation and the expression of microRNAs) are evolutionarily conserved. Insects offer a number of advantages over mammalian models including ethical acceptability, short generation times and the potential to investigate complex interacting parameters such as fecundity, longevity, gender ratio, and resistance to pathogens, parasites and environmental stress. © 2015 The Authors.

Loading TRM Ltd collaborators
Loading TRM Ltd collaborators